CAC
HGEN

Cowen and Company’s HUMANIGEN, INC. HGEN Stock Holding History

Cowen and Company’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,128,174
Closed -$2M – 808
2022
Q2 		$2M Buy
1,128,174
+378,174
+50% +$849K 0.19% 66
2022
Q1 		$2.26M Buy
+750,000
New +$2.01M 0.22% 63
2021
Q2 		– Sell
-2,097
Closed -$40K – 757
2021
Q1 		$40K Buy
+2,097
New +$38.3K ﹤0.01% 409

Other funds holding HGEN

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Cowen and Company's HGEN Position: Q3 2022 in Review

Cowen and Company sold out of HUMANIGEN, INC. (HGEN) in Q3 2022, closing a stake of 1,128,174 shares — an estimated $2M sold.

Cowen and Company first reported a position in HGEN in Q1 2021 and held it in 3 quarters. The position peaked at $2.26M in Q1 2022. 53 funds tracked by Wall St. Rank hold HGEN as of Q3 2022.

  • Cowen and Company reported no remaining HUMANIGEN, INC. position as of Q3 2022 after selling out during the quarter.
  • Cowen and Company sold 1,128,174 HUMANIGEN, INC. shares in Q3 2022, an estimated $2M.
  • Cowen and Company first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 3 quarters.
  • Cowen and Company's HUMANIGEN, INC. position peaked at $2.26M in Q1 2022.
  • 53 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2022.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.